Peripheral Artery Disease and Genetics: Is There a Cause-and-Effect Relationship?

References

• . Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344(21):1608–1621
   PubMed Web of Science ®Google Scholar
• . Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation. 1995;91(5):1472–1479
   PubMed Web of Science ®Google Scholar
• . Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA. 2008;299(11):1335–1344. Erratum in: JAMA. 2008;299(18):2150
   PubMed Web of Science ®Google Scholar
• . Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia. 1987;30(10):763–768
   PubMed Web of Science ®Google Scholar
• . Carmelli D, Robinette D, Fabsitz R. Concordance, discordance and prevalence of hypertension in World War II male veteran twins. J Hypertens. 1994;12(3):323–328
   PubMed Web of Science ®Google Scholar
• . Murabito JM, Guo CY, Fox CS, D'Agostino RB. Heritability of the ankle-brachial index: the Framingham Offspring study. Am J Epidemiol. 2006;164(10):963–968
   PubMed Web of Science ®Google Scholar
• . Kullo IJ, Turner ST, Kardia SL, Mosley TH Jr, Boerwinkle E, de Andrade M. A genome-wide linkage scan for ankle-brachial index in African American and non-Hispanic white subjects participating in the GENOA study. Atherosclerosis. 2006;187(2):433–438
   PubMed Web of Science ®Google Scholar
• . Allison MA, Criqui MH, McClelland RL,. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2006;48(6):1190–1197
   PubMed Web of Science ®Google Scholar
• . Valentine RJ, Verstraete R, Clagett GP, Cohen JC. Premature cardiovascular disease is common in relatives of patients with premature peripheral atherosclerosis. Arch Intern Med. 2000;160(9):1343–1348
   PubMedGoogle Scholar
• . Carmelli D, Fabsitz RR, Swan GE, Reed T, Miller B, Wolf PA. Contribution of genetic and environmental influences to ankle-brachial blood pressure index in the NHLBI Twin Study. National Heart, Lung, and Blood Institute. Am J Epidemiol. 2000;151(5):452–458
   PubMed Web of Science ®Google Scholar
• . Kuller L, Borhani N, Furberg C,. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol. 1994;139(12):1164–1179
   PubMed Web of Science ®Google Scholar
• . O'Donnell CJ, Cupples LA, D'Agostino RB,. Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study. BMC Med Genet. 2007;8( suppl 1):S4
   PubMed Web of Science ®Google Scholar
• . Fabsitz RR, Kalousdian S, Carmelli D, Robinette D, Christian JC. Characteristics of participants and nonparticipants in the NHLBI Twin Study. Acta Genet Med Gemellol (Roma). 1988;37(3–4):217–228
   PubMedGoogle Scholar
• . Strong JP, Richards ML. Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis. 1976;23(3):451–476
   PubMed Web of Science ®Google Scholar
• . Haapanen A, Koskenvuo M, Kaprio J, Kesäniemi YA, Heikkilä K. Carotid arteriosclerosis in identical twins discordant for cigarette smoking. Circulation. 1989;80(1):10–16
   PubMed Web of Science ®Google Scholar
• . Thorgeirsson T, Geller F, Sulem P,. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452(7187):638–641
   PubMed Web of Science ®Google Scholar
• . Hirsch AT, Haskal ZJ, Hertzer NR,; American Association for Vascular Surgery/Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)—summary of recommendations. J Vasc Interv Radiol. 2006;17(9):1383–1397
   PubMed Web of Science ®Google Scholar
• . Signorelli SS, Mazzarino MC, Spandidos DA, Malaponte G. Proinflammatory circulating molecules in peripheral arterial disease. Int J Mol Med. 2007;20(3):279–286
   PubMed Web of Science ®Google Scholar
• . Clark AG. The role of haplotypes in candidate gene studies. Genet Epidemiol. 2004;27(4):321–333
   PubMed Web of Science ®Google Scholar
• . Knowles JW, Assimes TL, Li J, Quertermous T, Cooke JP. Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology. Arterioscler Thromb Vasc Biol. 2007;27(10):2068–2078
   PubMed Web of Science ®Google Scholar
• . Mueller T, Marschon R, Dieplinger B,. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study. J Vasc Surg. 2005;41(5):808–815
   PubMed Web of Science ®Google Scholar
• . Renner W, Köppel H, Brodmann M,. Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease. Thromb Haemost. 2000;83(1):20–22
   PubMed Web of Science ®Google Scholar
• . Reny JL, Alhenc-Gelas M, Fontana P,. The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study. J Thromb Haemost. 2004;2(8):1334–1340
   PubMed Web of Science ®Google Scholar
• . Sofi F, Lari B, Rogolino A,. Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg. 2005;41(2):255–260
   PubMed Web of Science ®Google Scholar
• . Lee AJ, Fowkes FG, Lowe GD, Connor JM, Rumley A. Fibrinogen, factor VII and PAI−1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study. Thromb Haemost. 1999;81(4):553–560
   PubMed Web of Science ®Google Scholar
• . Renner W, Brodmann M, Pabst E, Stanger O, Wascher TC, Pilger E. The V34L polymorphism of factor XIII and peripheral arterial disease. Int Angiol. 2002;21(1):53–57
   PubMed Web of Science ®Google Scholar
• . Sabino A, Fernandes AP, Lima LM,. Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease. J Thromb Thrombolysis. 2009;27(1):82–87
   PubMed Web of Science ®Google Scholar
• . Todesco L, Angst C, Litynski P, Loehrer F, Fowler B, Haefeli WE. Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age. Eur J Clin Invest. 1999;29(12):1003–1009
   PubMed Web of Science ®Google Scholar
• . Renner W, Brodmann M, Winkler M, Washer TC, Pilger E. The PLA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with peripheral arterial disease. Thromb Haemost. 2001;85(4):745–746
   PubMed Web of Science ®Google Scholar
• . Smith FB, Connor JM, Lee AJ,. Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease. Thromb Res. 2003;112(4):209–216
   PubMed Web of Science ®Google Scholar
• . Smadja DM, Loriot MA, Hindorff LA, Mellottee L, Gaussem P, Emmerich J. No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease. Thromb Haemost. 2008;99(5):970–972
   PubMed Web of Science ®Google Scholar
• . Fowkes FG, Lee AJ, Hau CM, Cooke A, Connor JM, Lowe GD. Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study. Atherosclerosis. 2000;150(1):179–185
   PubMed Web of Science ®Google Scholar
• . Renner W, Pabst E, Paulweber B,. The angiotensin-converting-enzyme insertion/deletion polymorphism is not a risk factor for peripheral arterial disease. Atherosclerosis. 2002;165(1):175–178
   PubMed Web of Science ®Google Scholar
• . Taute BM, Handschug K, Taute R, Seifert H, Gläser C, Podhaisky H. Angiotensin-converting enzyme gene insertion/deletion polymorphism and peripheral arterial occlusive disease. Vasa. 1998;27(3):149–153
   PubMedGoogle Scholar
• . Başar Y, Salmayenli N, Aksoy M, Seçkin S, Aydin M, Ozkök E. ACE gene polymorphism in peripheral vascular disease. Horm Metab Res. 2007;39(7):534–537
   PubMed Web of Science ®Google Scholar
• . Karagiannis A, Balaska K, Tziomalos K,. Lack of an association between angiotensin converting enzyme gene polymorphism and peripheral arterial occlusive disease. Vasc Med. 2004;9(3):189–192
   PubMed Web of Science ®Google Scholar
• . Li R, Nicklas B, Pahor M,. Polymorphisms of angiotensinogen and angiotensin-converting enzyme associated with lower extremity arterial disease in the Health, Aging and Body Composition study. J Hum Hypertens. 2007;21(8):673–682
   PubMed Web of Science ®Google Scholar
• . Schillinger M, Exner M, Mlekusch W,. Heme oxygenase−1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb Res. 2002;106(2):131–136
   PubMed Web of Science ®Google Scholar
• . Danielsson P, Truedsson L, Eriksson KF, Norgren L. Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus. Vasc Med. 2005;10(3):191–198
   PubMed Web of Science ®Google Scholar
• . Flex A, Gaetani E, Pola R,. The −174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg. 2002;24(3):264–268
   PubMed Web of Science ®Google Scholar
• . Flex A, Gaetani E, Angelini F,. Pro-inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia. J Intern Med. 2007;262(1):124–130
   PubMed Web of Science ®Google Scholar
• . Potaczek DP, Undas A, Nowakowski T, Szczeklik A. Association between inflammatory markers and the interleukin-6−174 G/C polymorphism is abolished in peripheral arterial occlusive disease. Int Angiol. 2007;26(4):318–323
   PubMed Web of Science ®Google Scholar
• . Gugl A, Renner W, Seinost G,. Two polymorphisms in the fractalkine receptor CX3CR1 are not associated with peripheral arterial disease. Atherosclerosis. 2003;166(2):339–343
   PubMed Web of Science ®Google Scholar
• . Ghilardi G, Biondi ML, Battaglioli L, Zambon A, Guagnellini E, Scorza R. Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Delta 32 deletion. J Vasc Surg. 2004;40(5):995–1000
   PubMed Web of Science ®Google Scholar
• . Renner W, Schallmoser K, Gallippi P,. C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease. Atherosclerosis. 2000;152(1):175–179
   PubMed Web of Science ®Google Scholar
• . Gaetani E, Flex A, Pola R,. The K469E polymorphism of the ICAM−1 gene is a risk factor for peripheral arterial occlusive disease. Blood Coagul Fibrinolysis. 2002;13(6):483–488
   PubMed Web of Science ®Google Scholar
• . Jones GT, Phillips VL, Harris EL, Rossaak JI, van Rij AM. Functional matrix metalloproteinase-9 polymorphism (C−1562T) associated with abdominal aortic aneurysm. J Vasc Surg. 2003;38(6):1363–1367
   PubMed Web of Science ®Google Scholar
• . Catalano M, Cortelazzo A, Santi R,. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease. Clin Biochem. 2008;41(12):981–985
   PubMed Web of Science ®Google Scholar